InvestorsHub Logo
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Re: lasers post# 39215

Wednesday, 05/10/2017 12:55:47 PM

Wednesday, May 10, 2017 12:55:47 PM

Post# of 48316

At first $ONCS was going to pick up the cost, then UCSF picked up 100% of the cost for the prior trial.


Lasers, I don't think that's accurate. Please see below 2014 press release extract. UCSF was sponsoring from the get-go with Merck supplying the drug. ONCS only provided EP IL-12.

This Phase II clinical trial will be conducted as a multicenter Investigator Sponsored Trial (IST), with UCSF and Dr. Alain Algazi as the sponsor. Merck will supply pembrolizumab, and OncoSec will provide electroporation devices and plasmid IL-12. Enrollment is expected to begin in Q1 2015.


http://www.businesswire.com/news/home/20141125005162/en/UC-San-Francisco-OncoSec-Medical-Collaborate-Evaluate